Cancer Diagnosis Applications

In recent years, technological advancements and the growing demand for personalized healthcare have spurred significant progress in cancer diagnostics. Next-generation cancer diagnostics can significantly help to reduce the burden at all stages of the disease, from early detection to diagnosis, therapy management, and monitoring, during and after treatment.

Essential to modern healthcare, cancer diagnostics plays an irreplaceable role. It empowers healthcare providers with accurate diagnoses, optimal treatment choices, and treatment efficacy monitoring. Foremost, cancer diagnostics improves patient outcomes by establishing the diagnostic bedrock of effective healthcare.

The next-generation cancer diagnostics market grows steadily due to early diagnosis demand, and technological strides. It is estimated to grow from $8.7 billion in 2022 to $15 billion by 2027, with a compound annual growth rate (CAGR) of 11.5%.

In this event, we will explore this fascinating field, presented by 3 leading researchers from Tel-Aviv University.

Agenda:

Opening remarks by Dr. Ronen Kreizman, Ramot’s CEO.

Moderated by Dr. Shoshy Mizrahy, BD Manager, Life Science.

Three projects will be presented by:

• Prof. Ronit Satchi-Fainaro
• Prof. Noam Shomron
• Prof. Vered Padler-Karavani 

Each technology will be presented for about 10-15 min.

The event will last for approximately one hour. 

We are looking forward to seeing you!